Literature DB >> 24787439

Of nanobacteria, nanoparticles, biofilms and their role in health and disease: facts, fancy and future.

Jan Martel1, Hsin-Hsin Peng, David Young, Cheng-Yeu Wu, John D Young.   

Abstract

Nanobacteria have been at the center of a major scientific controversy in recent years owing to claims that they represent not only the smallest living microorganisms on earth but also new emerging pathogens associated with several human diseases. We and others have carefully examined these claims and concluded that nanobacteria are in fact nonliving mineralo-organic nanoparticles (NPs) that form spontaneously in body fluids. We have shown that these mineral particles possess intriguing biomimetic properties that include the formation of cell- and tissue-like morphologies and the possibility to grow, proliferate and propagate by subculture. Similar mineral NPs (bions) have now been found in both physiological and pathological calcification processes and they appear to represent precursors of physiological calcification cycles, which may at times go awry in disease conditions. Furthermore, by functioning at the nanoscale, these mineralo-organic NPs or bions may shed light on the fate of nanomaterials in the body, from both nanotoxicological and nanopathological perspectives.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24787439     DOI: 10.2217/nnm.13.221

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  10 in total

1.  Tetracycline attenuates calcifying nanoparticles-induced renal epithelial injury through suppression of inflammation, oxidative stress, and apoptosis in rat models.

Authors:  Yuqing Zhang; Rujian Zhu; Dong Liu; Min Gong; Wei Hu; Qingtong Yi; Jie Zhang
Journal:  Transl Androl Urol       Date:  2019-12

2.  Formation and characteristics of biomimetic mineralo-organic particles in natural surface water.

Authors:  Cheng-Yeu Wu; Jan Martel; Tsui-Yin Wong; David Young; Chien-Chun Liu; Cheng-Wei Lin; John D Young
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

3.  Pleomorphic bacteria-like structures in human blood represent non-living membrane vesicles and protein particles.

Authors:  Jan Martel; Cheng-Yeu Wu; Pei-Rong Huang; Wei-Yun Cheng; John D Young
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

4.  Role of calcifying nanoparticles in the development of testicular microlithiasis in vivo.

Authors:  Xia-Cong Lin; Xiang Gao; Gen-Sheng Lu; Bo Song; Qing-Hua Zhang
Journal:  BMC Urol       Date:  2017-10-30       Impact factor: 2.264

5.  Comprehensive organic profiling of biological particles derived from blood.

Authors:  Cheng-Yeu Wu; Jan Martel; John D Young
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

Review 6.  A Brief Review about the Role of Nanomaterials, Mineral-Organic Nanoparticles, and Extra-Bone Calcification in Promoting Carcinogenesis and Tumor Progression.

Authors:  Marina Senchukova
Journal:  Biomedicines       Date:  2019-08-28

7.  Physical attributes of salivary calcium particles and their interaction with gingival epithelium.

Authors:  Hsin-Hsin Peng; Pei-Rong Huang; John D Young; David M Ojcius
Journal:  Biomed J       Date:  2020-05-23       Impact factor: 4.910

8.  Detection and characterization of mineralo-organic nanoparticles in human kidneys.

Authors:  Tsui-Yin Wong; Cheng-Yeu Wu; Jan Martel; Cheng-Wei Lin; Fu-Yung Hsu; David M Ojcius; Paul Y Lin; John D Young
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

9.  Mineral particles stimulate innate immunity through neutrophil extracellular traps containing HMGB1.

Authors:  Hsin-Hsin Peng; Yu-Ju Liu; David M Ojcius; Chiou-Mei Lee; Ren-Hao Chen; Pei-Rong Huang; Jan Martel; John D Young
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

Review 10.  Recent advances on the mechanisms of kidney stone formation (Review).

Authors:  Zhu Wang; Ying Zhang; Jianwen Zhang; Qiong Deng; Hui Liang
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.